Activated leukocyte cell adhesion molecule: a new paradox in cancer

Translational Research

Volumn 151, Issue 3, 2008, Pages 122-128

  Ofori Acquah, Solomon F ^a   King, Judy A ^b  

^a AFLAC   (United States)

^b UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE;

BLADDER CANCER; BREAST CANCER; CELL ADHESION; CELL LINEAGE; COLORECTAL CARCINOMA; ESOPHAGUS CARCINOMA; HUMAN; MALIGNANT NEOPLASTIC DISEASE; MELANOMA; METASTASIS; METASTASIS POTENTIAL; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CARCINOMA; PROTEIN EXPRESSION; REVIEW; TRANSCRIPTION REGULATION;

EID: 38949171709     PISSN: 19315244     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trsl.2007.09.006     Document Type: Review

References (56)

1. Fidler I., and Nicolson G. Concepts and mechanisms of breast cancer metastasis. In: Bland K., and Copeland E. (Eds). The breast (1991), W. B. Saunders, Philadelphia, Pa 395-408
2. Al-Mehdi A.-B., Tozawa K., Fisher A., Shientag L., Lee A., and Muschel R. Intravascular origin of metastasis from the proliferation of endothelium-attached tumor cells: a new model for metastasis. Nature Med 6 (2000) 100-101
3. Hart I.R., and Fidler I.J. Cancer invasion and metastasis. Q Rev Biol 55 (1980) 121-142
4. Pollard T.D., and Earnshaw W.C. Cellular adhesion. Cell biology (2002), Saunders, Philadelphia, Pa 507-524
5. Swart G.W. Activated leukocyte cell adhesion molecule (CD166/ALCAM): developmental and mechanistic aspects of cell clustering and cell migration. Eur J Cell Biol 81 (2002) 313-321
6. Pourquie O., Corbel C., Le Caer J.-P., Rossier J., and Le Douarin N. BEN, surface glycoprotein of the immunoglobulin superfamily, is expressed in a variety of developing systems. Proc Natl Acad Sci U S A 89 (1992) 5261-5265
7. Tanaka H., Matsui T., Agata A., et al. Molecular cloning and expression of a novel adhesion molecule, SC1. Neuron 7 (1991) 535-545
8. Burns F., von Kannen S., Guy L., Raper J., Kamholz J., and Chang S. DM-GRASP, a novel immunoglobulin superfamily axonal surface protein that supports neurite extension. Neuron 7 (1991) 209-220
9. Peduzzi J., Irwin M., and Geisert E. Distribution and characteristics of a 90 kDa protein, KG-CAM in the rat and CNS. Brain Res 640 (1994) 296-307
10. Paschke K., Lottspeich F., and Stuermer C. Neurolin, a cell surface glycoprotein on growing retinal axons in the goldfish visual systems, is reexpressed during retinal axonal regeneration. J Cell Biol 117 (1992) 863-875
11. Alia T., Bruder S.P., Ricalton N.S., et al. Mesenchymal stem cell surface antigen SB-10 corresponds to activated leukocyte cell adhesion molecule and is involved in osteogenic differentiation. J Bone Miner Res 13 (1998) 655-663
12. Degen W., van Kempen L., Gijzen E., et al. MEMD, a new cell adhesion molecule in metastasizing human melanoma cell lines, is identical to ALCAM (activated leukocyte cell adhesion molecule). Am J Pathol 152 (1998) 805-813
13. Bowen M., Bajorath J., D'Egidio M., et al. Characterization of mouse ALCAM (CD166): the CD6-binding domain is conserved in different homologs and mediates cross-species binding. Eur J Immunol 27 (1997) 1469-1478
14. Bowen M.A., Patel D.D., Li X., et al. Cloning, mapping, and characterization of activated leukocyte-cell adhesion molecule (ALCAM), a CD6 ligand. J Exp Med 181 (1995) 2213-2220
15. Kurata H., Matsumoto A., Fujiwara Y., et al. A candidate high density lipoprotein (HDL) receptor, HB2, with possible multiple functions shows sequence homology with adhesion molecules. J Atheroscler Thromb 4 (1998) 112-117
16. Matsumoto A., Mitchell A., Kurata H., et al. Cloning and characterization of HB2, a candidate high density lipoprotein receptor. Sequence homology with members of the immunoglobulin superfamily of membrane proteins. J Biol Chem 272 (1997) 16778-16782
17. van Kempen L.C., Nelissen J.M., Degen W.G., et al. Molecular basis for the homophilic activated leukocyte cell adhesion molecule (ALCAM)-ALCAM interaction. J Biol Chem 276 (2001) 25783-25790
18. Kanki J.P., Chang S., and Kuwada J.Y. The molecular cloning and characterization of potential chick DM-GRASP homologs in zebrafish and mouse. J Neurobiol 25 (1994) 831-845
19. Laessing U., Giordano S., Stecher B., Lottspeich F., and Stuermer C.A. Molecular characterization of fish neurolin: a growth-associated cell surface protein and member of the immunoglobulin superfamily in the fish retinotectal system with similarities to chick protein DM-GRASP/SC-1/BEN. Differentiation 56 (1994) 21-29
20. Denzinger T., Diekmann H., Bruns K., Laessing U., Stuermer C.A., and Przybylski M. Isolation, primary structure characterization and identification of the glycosylation pattern of recombinant goldfish neurolin, a neuronal cell adhesion protein. J Mass Spectrom 34 (1999) 435-446
21. Ikeda K., and Quertermous T. Molecular isolation and characterization of a soluble isoform of activated leukocyte cell adhesion molecule that modulates endothelial cell function. J Biol Chem 279 (2004) 55315-55323
22. Tan F., Mbeunkui F., Harris C., and Ofori-Acquah S. Mechanisms for transcriptional activation of the human activated leukocyte cell adhesion molecule gene and its silencing by immunosuppressive toxins. Blood 108 suppl 1 (2006) 1637
23. Zhang G., Slaughter C., and Humphries E.H. v-rel Induces ectopic expression of an adhesion molecule, DM-GRASP, during B-lymphoma development. Mol Cell Biol 15 (1995) 1806-1816
24. Masedunskas A., King J.A., Tan F., et al. Activated leukocyte cell adhesion molecule is a component of the endothelial junction involved in transendothelial monocyte migration. FEBS Lett 580 (2006) 2637-2645
25. Weiner J.A., Koo S.J., Nicolas S., et al. Axon fasciculation defects and retinal dysplasias in mice lacking the immunoglobulin superfamily adhesion molecule BEN/ALCAM/SC1. Mol Cell Neurosci 27 (2004) 59-69
26. Aruffo A., Bowen M.A., Patel D.D., et al. CD6-ligand interactions: a paradigm for SRCR domain function?. Immunol Today 18 (1997) 498-504
27. Bajorath J., Bowen M.A., and Aruffo A. Molecular model of the N-terminal receptor-binding domain of the human CD6 ligand ALCAM. Protein Sci 4 (1995) 1644-1647
28. Bowen M.A., Bajorath J., Siadak A.W., et al. The amino-terminal immunoglobulin-like domain of activated leukocyte cell adhesion molecule binds specifically to the membrane-proximal scavenger receptor cysteine-rich domain of CD6 with a 1:1 stochiometry. J Biol Chem 271 (1996) 17390-17396
29. Gimferrer I., Calvo M., Mittelbrunn M., et al. Relevance of CD6-mediated interactions in T cell activation and proliferation. J Immunol 173 (2004) 2262-2270
30. Hassan N.J., Barclay A.N., and Brown M.H. Frontline: optimal T cell activation requires the engagement of CD6 and CD166. Eur J Immunol 34 (2004) 930-940
31. Kato Y., Tanaka Y., Hayashi M., Okawa K., and Minato N. Involvement of CD166 in the activation of human gamma delta T cells by tumor cells sensitized with nonpeptide antigens. J Immunol 177 (2006) 877-884
32. Patel D.D., Wee S.F., Whichard L.P., et al. Identification and characterization of a 100-kD ligand for CD6 on human thymic epithelial cells. J Exp Med 181 (1995) 1563-1568
33. Singer N.G., Richardson B.C., Powers D., et al. Role of the CD6 glycoprotein in antigen-specific and autoreactive responses of cloned human T lymphocytes. Immunology 88 (1996) 537-543
34. Singer N.G., Mitra R., Lialios F., et al. CD6 dependent interactions of T cells and keratinocytes: functional evidence for a second CD6 ligand on gamma-interferon activated keratinocytes. Immunol Lett 58 (1997) 9-14
35. Starling G.C., Whitney G.S., Siadak A.W., et al. Characterization of mouse CD6 with novel monoclonal antibodies which enhance the allogeneic mixed leukocyte reaction. Eur J Immunol 26 (1996) 738-746
36. Zimmerman A.W., Joosten B., Torensma R., Parnes J.R., van Leeuwen F.N., and Figdor C.G. Long-term engagement of CD6 and ALCAM is essential for T-cell proliferation induced by dendritic cells. Blood 107 (2006) 3212-3220
37. Swart G.W., Lunter P.C., Kilsdonk J.W., and Kempen L.C. Activated leukocyte cell adhesion molecule (ALCAM/CD166): signaling at the divide of melanoma cell clustering and cell migration?. Cancer Metastasis Rev 24 (2005) 223-236
38. van Kempen L.C., van den Oord J.J., van Muijen G.N., Weidle U.H., Bloemers H.P., and Swart G.W. Activated leukocyte cell adhesion molecule/CD166, a marker of tumor progression in primary malignant melanoma of the skin. Am J Pathol 156 (2000) 769-774
39. van Kempen L.C., Meier F., Egeblad M., et al. Truncation of activated leukocyte cell adhesion molecule: a gateway to melanoma metastasis. J Invest Dermatol 122 (2004) 1293-1301
40. Klein W.M., Wu B.P., Zhao S., Wu H., Klein-Szanto A.J., and Tahan S.R. Increased expression of stem cell markers in malignant melanoma. Mod Pathol 20 (2007) 102-107
41. Lunter P.C., van Kilsdonk J.W., van Beek H., et al. Activated leukocyte cell adhesion molecule (ALCAM/CD166/MEMD), a novel actor in invasive growth, controls matrix metalloproteinase activity. Cancer Res 65 (2005) 8801-8808
42. Tomita K., van Bokhoven A., Jansen C.F., Bussemakers M.J., and Schalken J.A. Coordinate recruitment of E-cadherin and ALCAM to cell-cell contacts by alpha-catenin. Biochem Biophys Res Commun 267 (2000) 870-874
43. Stamey T.A., Warrington J.A., Caldwell M.C., et al. Molecular genetic profiling of Gleason grade 4/5 prostate cancers compared to benign prostatic hyperplasia. J Urol 166 (2001) 2171-2177
44. Kristiansen G., Pilarsky C., Wissmann C., et al. ALCAM/CD166 is up-regulated in low-grade prostate cancer and progressively lost in high-grade lesions. Prostate 54 (2003) 34-43
45. Kristiansen G., Pilarsky C., Wissmann C., et al. Expression profiling of microdissected matched prostate cancer samples reveals CD166/MEMD and CD24 as new prognostic markers for patient survival. J Pathol 205 (2005) 359-376
46. King J.A., Chambers Z., Kleinfeld S., et al. Potential role of activated leukocyte cell adhesion molecule (ALCAM/CD166) in metastasis of breast cancer cells to the lung. Proc Amer Assoc Cancer Res 47 (2006) 2784
47. King J.A., Ofori-Acquah S.F., Stevens T., Al-Mehdi A.B., Fodstad O., and Jiang W.G. Activated leukocyte cell adhesion molecule in breast cancer: prognostic indicator. Breast Cancer Res 6 (2004) R478-R487
48. Davies S, Dent C, Watkins G, King JA, Mokbel K, Jiang WG. Expression of the cell to cell activated leukocyte cell adhesion molecule in breast cancer patients and the potential link with skeletal metastasis. Oncology Reports. In press.
49. Burkhardt M., Mayordomo E., Winzer K.J., et al. Cytoplasmic overexpression of ALCAM is prognostic of disease progression in breast cancer. J Clin Pathol 59 (2006) 403-409
50. Jezierska A., Olszewski W.P., Pietruszkiewicz J., Olszewski W., Matysiak W., and Motyl T. Activated leukocyte cell adhesion molecule (ALCAM) is associated with suppression of breast cancer cells invasion. Med Sci Monit 12 (2006) BR245-BR256
51. Jezierska A., Matysiak W., and Motyl T. ALCAM/CD166 protects breast cancer cells against apoptosis and autophagy. Med Sci Monit 12 (2006) BR263-BR273
52. Doane A.S., Danso M., Lal P., et al. An estrogen receptor-negative breast cancer subset characterized by a hormonally regulated transcriptional program and response to androgen. Oncogene 25 (2006) 3994-4008
53. Milde-Langosch K, Janke S, Wagner I, et al. Role of Fra-2 in breast cancer: influence on tumor cell invasion and motility. Breast Cancer Res Treat. In press.
54. Weichert W., Knosel T., Bellach J., Dietel M., and Kristiansen G. ALCAM/CD166 is overexpressed in colorectal carcinoma and correlates with shortened patient survival. J Clin Pathol 57 (2004) 1160-1164
55. Tomita K., van Bokhoven A., Jansen C.F.J., et al. Activated leukocyte cell adhesion molecule (ALCAM) expression is associated with a poor prognosis for bladder cancer patients. UroOncology 3 (2003) 121-129
56. Verma A., Shukla N.K., Deo S.V., Gupta S.D., and Ralhan R. MEMD/ALCAM: a potential marker for tumor invasion and nodal metastasis in esophageal squamous cell carcinoma. Oncology 68 (2005) 462-470